Literature DB >> 9149702

Efficacy of camptothecin in progressive multifocal leucoencephalopathy.

J Vollmer-Haase, P Young, E B Ringelstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149702     DOI: 10.1016/S0140-6736(05)63201-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Camptothecin delivery methods.

Authors:  A Hatefi; B Amsden
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Progressive Multifocal Leukoencephalopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 3.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 4.  HIV-associated neurological disorders: a guide to pharmacotherapy.

Authors:  Ik L Tan; Justin C McArthur
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

Review 5.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

7.  Progressive Multifocal Leukoencephalopathy.

Authors:  Anna R. Thorner; Joel T. Katz
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

8.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.